Danaher Corp (DHR) Financial Statements

Danaher's financial health presents a nuanced picture. On quality, the 4.0% free cash flow yield is a solid indicator of cash generation, though the framework's >10-15% FCF margin benchmark is not calculable from the data provided. The balance sheet is healthy with a Debt/Equity ratio of 0.35, which is comfortably below the framework's caution threshold of 1.0x Debt/EBITDA. However, key profitability metrics are currently subdued; an ROE of 6.9% falls well short of the desirable >15-20% ROIC, and the 14.7% profit margin suggests moderate efficiency after all costs. Revenue growth of 4.6% YoY is modest and does not meet the framework's standard for consistent double-digit growth, indicating a mature phase. The operating margin of 19.1% is respectable but lacks context on whether it is expanding, a key factor for operating leverage. Overall, the company demonstrates financial stability and cash generation, but its current returns on capital and growth trajectory are not aligned with the high-quality, high-growth profile typically sought in the framework's early gates. The significant premium of the current price to the GoodMoat target further complicates the value proposition. Analysis based on data as of 2024-05-15.